Followers | 2459 |
Posts | 79990 |
Boards Moderated | 0 |
Alias Born | 06/15/2009 |
Tuesday, December 28, 2021 7:27:56 AM
Recent CNTX News
- Form 8-K - Current report • Edgar (US Regulatory) • 09/17/2024 08:22:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/04/2024 11:34:25 AM
- Context Therapeutics Appoints Dr. Karen Smith and Dr. Luke Walker to Board of Directors • GlobeNewswire Inc. • 09/04/2024 11:30:47 AM
- Context Therapeutics Reports Second Quarter 2024 Operating and Financial Results • GlobeNewswire Inc. • 08/07/2024 08:17:13 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/07/2024 08:07:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/01/2024 09:18:30 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/01/2024 09:15:17 PM
- Context Therapeutics Appoints Chief Medical Officer and Vice President of Clinical Operations • GlobeNewswire Inc. • 08/01/2024 11:30:00 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 07/24/2024 09:07:18 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 07/24/2024 08:55:48 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 07/12/2024 08:04:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/10/2024 11:33:59 AM
- Context Therapeutics Acquires Phase 1-ready T cell Engager CT-95 • GlobeNewswire Inc. • 07/10/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/14/2024 11:50:14 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/14/2024 11:34:52 AM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 06/03/2024 04:15:21 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/31/2024 08:06:51 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 05/24/2024 08:15:19 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 05/24/2024 11:31:07 AM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 05/10/2024 08:00:06 PM
- Context Therapeutics Reports First Quarter 2024 Operating and Financial Results • GlobeNewswire Inc. • 05/08/2024 08:06:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2024 08:03:39 PM
- Context Therapeutics Announces FDA Clearance of IND Application for a Phase 1 Clinical Trial of CTIM-76 • GlobeNewswire Inc. • 05/02/2024 11:31:53 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM